These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

735 related articles for article (PubMed ID: 34125455)

  • 41. Molecular diversity of coronavirus host cell entry receptors.
    Millet JK; Jaimes JA; Whittaker GR
    FEMS Microbiol Rev; 2021 May; 45(3):. PubMed ID: 33118022
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evolutionary and structural analyses of SARS-CoV-2 D614G spike protein mutation now documented worldwide.
    Isabel S; Graña-Miraglia L; Gutierrez JM; Bundalovic-Torma C; Groves HE; Isabel MR; Eshaghi A; Patel SN; Gubbay JB; Poutanen T; Guttman DS; Poutanen SM
    Sci Rep; 2020 Aug; 10(1):14031. PubMed ID: 32820179
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In silico investigation of critical binding pattern in SARS-CoV-2 spike protein with angiotensin-converting enzyme 2.
    Jafary F; Jafari S; Ganjalikhany MR
    Sci Rep; 2021 Mar; 11(1):6927. PubMed ID: 33767306
    [TBL] [Abstract][Full Text] [Related]  

  • 44. SARS-CoV-2, the pandemic coronavirus: Molecular and structural insights.
    Kadam SB; Sukhramani GS; Bishnoi P; Pable AA; Barvkar VT
    J Basic Microbiol; 2021 Mar; 61(3):180-202. PubMed ID: 33460172
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Structural impact on SARS-CoV-2 spike protein by D614G substitution.
    Zhang J; Cai Y; Xiao T; Lu J; Peng H; Sterling SM; Walsh RM; Rits-Volloch S; Zhu H; Woosley AN; Yang W; Sliz P; Chen B
    Science; 2021 Apr; 372(6541):525-530. PubMed ID: 33727252
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Computational Alanine Scanning and Structural Analysis of the SARS-CoV-2 Spike Protein/Angiotensin-Converting Enzyme 2 Complex.
    Laurini E; Marson D; Aulic S; Fermeglia M; Pricl S
    ACS Nano; 2020 Sep; 14(9):11821-11830. PubMed ID: 32833435
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Free SARS-CoV-2 Spike Protein S1 Particles May Play a Role in the Pathogenesis of COVID-19 Infection.
    Letarov AV; Babenko VV; Kulikov EE
    Biochemistry (Mosc); 2021 Mar; 86(3):257-261. PubMed ID: 33838638
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mutations in membrane-fusion subunit of spike glycoprotein play crucial role in the recent outbreak of COVID-19.
    Podder S; Ghosh A; Ghosh T
    J Med Virol; 2021 May; 93(5):2790-2798. PubMed ID: 33090493
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Susceptibilities of Human ACE2 Genetic Variants in Coronavirus Infection.
    Ren W; Zhu Y; Lan J; Chen H; Wang Y; Shi H; Feng F; Chen DY; Close B; Zhao X; Wu J; Tian B; Yuan Z; Zhou D; Saeed M; Wang X; Zhang R; Ding Q
    J Virol; 2022 Jan; 96(1):e0149221. PubMed ID: 34668773
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Host Cell and SARS-CoV-2-Associated Molecular Structures and Factors as Potential Therapeutic Targets.
    Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Roshan R; Azam F; Mehta J; Handu S; Prasad R; Jain N; Pandey AK; Dhamija P
    Cells; 2021 Sep; 10(9):. PubMed ID: 34572076
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Protein structure analysis of the interactions between SARS-CoV-2 spike protein and the human ACE2 receptor: from conformational changes to novel neutralizing antibodies.
    Mercurio I; Tragni V; Busto F; De Grassi A; Pierri CL
    Cell Mol Life Sci; 2021 Feb; 78(4):1501-1522. PubMed ID: 32623480
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Containing the spread of COVID-19 virus facing to its high mutation rate: approach to intervention using a nonspecific way of blocking its entry into the cells.
    Nguyen KV
    Nucleosides Nucleotides Nucleic Acids; 2022; 41(8):778-814. PubMed ID: 35532338
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Coronavirus disease 2019 (COVID-19): Biophysical and biochemical aspects of SARS-CoV-2 and general characteristics.
    Güler G; Özdemir H; Omar D; Akdoğan G
    Prog Biophys Mol Biol; 2021 Sep; 164():3-18. PubMed ID: 34033836
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Structural basis of severe acute respiratory syndrome coronavirus 2 infection.
    Ge J; Zhang S; Zhang L; Wang X
    Curr Opin HIV AIDS; 2021 Jan; 16(1):74-81. PubMed ID: 33186231
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparative analysis reveals the species-specific genetic determinants of ACE2 required for SARS-CoV-2 entry.
    Ren W; Zhu Y; Wang Y; Shi H; Yu Y; Hu G; Feng F; Zhao X; Lan J; Wu J; Kenney DJ; Douam F; Tong Y; Zhong J; Xie Y; Wang X; Yuan Z; Zhou D; Zhang R; Ding Q
    PLoS Pathog; 2021 Mar; 17(3):e1009392. PubMed ID: 33760889
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effect of the D614G substitution on the structure of the spike glycoprotein of SARS-CoV-2.
    Benton DJ; Wrobel AG; Roustan C; Borg A; Xu P; Martin SR; Rosenthal PB; Skehel JJ; Gamblin SJ
    Proc Natl Acad Sci U S A; 2021 Mar; 118(9):. PubMed ID: 33579792
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Coevolutionary forces shaping the fitness of SARS-CoV-2 spike glycoprotein against human receptor ACE2.
    Priya P; Shanker A
    Infect Genet Evol; 2021 Jan; 87():104646. PubMed ID: 33249264
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cell entry by SARS-CoV-2.
    Peng R; Wu LA; Wang Q; Qi J; Gao GF
    Trends Biochem Sci; 2021 Oct; 46(10):848-860. PubMed ID: 34187722
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Acquisition of Furin Cleavage Site and Further SARS-CoV-2 Evolution Change the Mechanisms of Viral Entry, Infection Spread, and Cell Signaling.
    Frolova EI; Palchevska O; Lukash T; Dominguez F; Britt W; Frolov I
    J Virol; 2022 Aug; 96(15):e0075322. PubMed ID: 35876526
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Contribution of Syndecans to the Cellular Entry of SARS-CoV-2.
    Hudák A; Letoha A; Szilák L; Letoha T
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.